Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.96 +1.08 (+0.42%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
RESMED INC (NYSE:RMD) – A Strong Candidate for Quality Investors
RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional ROIC, and solid cash flow, making it a standout pick for long-term investors. 
Via Chartmill
2 Cash-Producing Stocks to Consider Right Now and 1 to Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Looking Back on a Motley Fool Career
Via The Motley Fool
ResMed: A Mixed Bag for Investors Amid Rising Competition
Via The Motley Fool
Earnings Scheduled For April 23, 2025
Via Benzinga
RESMED INC (NYSE:RMD) – A Strong Contender for Quality Investors
RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors. 
Via Chartmill
2 Large-Cap Stocks with Competitive Advantages and 1 to Approach with Caution
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Topics Fraud
3 Cash-Heavy Stocks with Competitive Advantages
Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. Without interest payments being less of a worry, these businesses can invest... 
Via StockStory
2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
1 Surging Stock with Exciting Potential and 2 to Avoid
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved
RBC Capital noted that ResMed now has “a number of competitive threats on the horizon." 
Via Stocktwits
Topics Government
What's going on in today's pre-market session: S&P500 movers
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session. 
Via Chartmill
1 Unpopular Stock that Should Get More Attention and 2 to Brush Off
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
RESMED INC (NYSE:RMD) – A Quality Stock with Strong Fundamentals
RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional profitability, and a solid balance sheet, making it a standout pick for long-term investors. 
Via Chartmill
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
Via The Motley Fool
Topics Retirement
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
3 Profitable Stocks to Consider Right Now
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting... 
Via StockStory
What's going on in today's session: S&P500 gap up and gap down stocks
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends. 
Via Chartmill
RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with... 
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast
ResMed posted Q3 EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions. 
Via Benzinga
Topics World Trade
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade... 
Via Benzinga
Topics Government World Trade
Resmed Stock Rises Pre-Market On Upbeat Earnings, CEO Dismisses Tariff Impact: Retail Is Bullish
Revenue for the three months through the end of March rose 8% to $1.29 billion, in line with analyst estimates. 
Via Stocktwits
Topics Earnings Economy Government
Which S&P500 stocks are moving after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session. 
Via Chartmill
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with... 
Via StockStory
Topics Artificial Intelligence
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS